Salar Husein Karim

Salar Husein Karim

Auto-generated profile, based on publicly available information

Salar Husein Karim

Chemical Weapon Victim’s Hospital, Halabja General Directorate of Health, Halabja 46018, Iraq

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Polytechnic Journal
Verified
Journal Article
Open access
PDF file
TATareq H. Abdullah
Tareq H. Abdullah
HBHardi R. Baqi
Hardi R. Baqi
SKSalar H. Karim
Salar H. Karim
DGDashti A. Ghafor
Dashti A. Ghafor
Obesity and overweight are extensive phenomena that reached epidemics extent worldwide, including the Kurdistan region of Iraq. The aim of this study is to evaluate the values of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), body mass index (BMI), and the state of physical activity in Halabja’s public employees. Overall 355 adults aged from 19 to 63 including 246 males and 109 females contributed to the study. The lipid profiles were tested in all subjects after over-night fasting. In addition, anthropometry measurements were taken; the mean height for males is 1.7129 m and 1.5732 m for females. The mean weights of males and females are 80.4813 and 69.9459 kg, respectively. The mean BMI value for males and females is 27.4258 and 28.3274, respectively. Some of the cases were diagnosed with diabetes, renal diseases, hypertension, and other relevant diseases. 246 of participants adopted sedentary lifestyles while 109 of them lived an active lifestyle. 65, 162, 98, and 206 of participants had TC, TG, LDL-C, and HDL-C off-limits, respectively. Pearson’s correlation between BMI with TC, TG, and LDL-C showed a significant relationship at 0.01 level as 0.156**, 0.140**, and 0.144**, respectively. HDL-C was negatively correlated to BMI at −0.062 level. The analysis of variance showed statistically significant p-values between TC, TG, and HDL-C according to BMI at 0.027, 0.000, and 0.000, respectively. The sedentary group of participants showed a higher Mean range of TC, TG, LDL-C, and HDL-C than an active group of participants.

14 November 2025 in Trends in Immunotherapy
Verified
Journal Article
Open access
DLDzhumaeva Lazokatkhon
Dzhumaeva Lazokatkhon
HAHazim Abdul Rahman Alhiti
Hazim Abdul Rahman Alhiti
OBOthman Farooq Bakr
Othman Farooq Bakr
MSMudhafar A. Shafiq
Mudhafar A. Shafiq
TAThamer Al-Hilfi
Thamer Al-Hilfi
SKSalar Husein Karim
Salar Husein Karim
Considering what was said about Heat Shock Proteins (HSPs) role in the presentation of tumor antigens, today, before using tumor cell extracts as antigens in vaccine preparation, researchers try to increase the efficiency of antigen presentation by APCs via inducing these proteins; however, since different cell lines express different amounts of HSPs under the influence of different temperatures and different incubation times, discussing the optimal temperature and post-temperature incubation for cancer cell lines that may cause the next stages of the production of cancer cell vaccines, will be very useful. Through systematic search in PubMed/Medline using ("Tumor"[Title/Abstract] OR "Cancer"[Title/Abstract] OR "Neoplasm"[Title/Abstract]) AND ("vaccine"[Title/Abstract] OR "vaccination"[Title/Abstract]) AND ("heat shock protein"[Title/Abstract] OR "HSP"[Title/Abstract]) from 1980 to 2025. Overall, 18 articles were selected from a total of 414. The results of clinical trials confirm the use of HSPs in cancer vaccine therapy. A total of 18 studies, including 1,116 cases with different forms of cancer, were reviewed. These studies spanned different trial phases (I–III) and utilized a range of HSP-based vaccines to evaluate their safety, immunogenicity, and efficacy. HSPPC-96 was the most commonly investigated vaccine. These results indicate that the specific tumor-specific effects of the HSPs' immune response, including cluster of differentiation 4 (CD4+), interferon gamma (IFN-γ), and CD8+, lead to a much stronger vaccination. These outcomes underscore the complexity of the tumor microenvironment and the necessity for tailored approaches to maximize therapeutic success. Advances in vaccine formulation, production, and combination therapies offer promising pathways to address these challenges.

28 October 2025 in Exploration of Immunology
Verified
Journal Article
Open access
PDF file
FRFakher Rahim
Fakher Rahim
SGShamim Gozin
Shamim Gozin
SKSalar Husein Karim
Salar Husein Karim
AQAinur Bakdauletkyzy Qumar
Ainur Bakdauletkyzy Qumar
KDKobra Doostali
Kobra Doostali
BIBalday - Issenova
Balday - Issenova
Cancer treatment regimens are significantly more intricate than commonly perceived. Nonetheless, both immunotherapy and chemotherapy may produce adverse consequences. Immunotherapy represents a significant advancement in the battle against cancer; nonetheless, it is not devoid of challenges. This research elucidates the mechanisms underlying immunotherapy-induced cardiovascular damage, highlighting the significant role of immune regulators, such as soluble urokinase plasminogen activator receptor (suPAR), in inducing vascular leakage. We also examine the role of matrix metalloproteinase (MMP14/15) in this process, and antigens associated with cardiovascular illness and malignancies, including native proteins, mutated tumor antigens, and viral components. Besides, we studied predictive biomarkers, such as circulating T-cell populations associated with the probability of myocarditis. We discuss treatment approaches and strategies to mitigate these issues, particularly through the use of antihypertensive medications to reduce their impact. Losartan alters the tumor microenvironment (TME) to improve immunotherapy. It restores immune effector cells in triple-negative breast cancer (TNBC), overcomes resistance in unresponsive tumors, and modifies TMEs’ immune system suppression in ovarian cancer and melanoma. It is important to note that its effects differ by cancer kind. It may promote fibrosarcoma tumor growth and improve cholangiocarcinoma treatment. This shows that losartan’s dangers in cancer treatment should be carefully considered and that more research is needed. This suggests that there must be careful consideration of the potential risks associated with losartan use in cancer treatment and underscores the requirement for additional research on this topic. This study may enhance our comprehension and management of cardiovascular adverse effects in cancer immunotherapy by integrating novel insights on immunological predictors and vascular dysfunction. Experts assert that oncology programs must provide and promote continuous monitoring of cardiac health for breast cancer patients. To mitigate the risk of cardiovascular disease in this demographic, comprehensive patient care must be administered.